Clinical Trials · NCT01674140
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
- Phase
- Phase 3
- Recruitment status
- Active Not Recruiting
- Sponsor
- SWOG Cancer Research Network
- Enrollment
- 1,939
- Start date
- Sep 2013
- Locations
- 1459 sites, United States, Puerto Rico
- Primary endpoint
- Invasive Disease-Free Survival (IDFS)